210 related articles for article (PubMed ID: 18029752)
21. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
22. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome.
Tanaka Y; Shimoike T; Ishii K; Suzuki R; Suzuki T; Ushijima H; Matsuura Y; Miyamura T
Virology; 2000 Apr; 270(1):229-36. PubMed ID: 10772995
[TBL] [Abstract][Full Text] [Related]
23. NMR structures of loop B RNAs from the stem-loop IV domain of the enterovirus internal ribosome entry site: a single C to U substitution drastically changes the shape and flexibility of RNA.
Du Z; Ulyanov NB; Yu J; Andino R; James TL
Biochemistry; 2004 May; 43(19):5757-71. PubMed ID: 15134450
[TBL] [Abstract][Full Text] [Related]
24. Regulating mRNA translation with a kiss.
Dausse E; Belair C; Staedel C; Toulmé JJ
Nucleic Acids Symp Ser (Oxf); 2008; (52):711-2. PubMed ID: 18776578
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hepatitis C virus IRES-mediated translation by small RNAs analogous to stem-loop structures of the 5'-untranslated region.
Ray PS; Das S
Nucleic Acids Res; 2004; 32(5):1678-87. PubMed ID: 15020704
[TBL] [Abstract][Full Text] [Related]
26. An RNA aptamer containing two binding sites against the HCV minus-IRES domain I.
Konno K; Iizuka M; Fujita S; Nishikawa S; Hasegawa T; Fukuda K
Nucleosides Nucleotides Nucleic Acids; 2011 Mar; 30(3):185-202. PubMed ID: 21491328
[TBL] [Abstract][Full Text] [Related]
27. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
[TBL] [Abstract][Full Text] [Related]
28. The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro.
Cristofari G; Ivanyi-Nagy R; Gabus C; Boulant S; Lavergne JP; Penin F; Darlix JL
Nucleic Acids Res; 2004; 32(8):2623-31. PubMed ID: 15141033
[TBL] [Abstract][Full Text] [Related]
29. Domains I and II in the 5' nontranslated region of the HCV genome are required for RNA replication.
Kim YK; Kim CS; Lee SH; Jang SK
Biochem Biophys Res Commun; 2002 Jan; 290(1):105-12. PubMed ID: 11779140
[TBL] [Abstract][Full Text] [Related]
30. Functional analyses of RNA structures shared between the internal ribosome entry sites of hepatitis C virus and the picornavirus porcine teschovirus 1 Talfan.
Chard LS; Kaku Y; Jones B; Nayak A; Belsham GJ
J Virol; 2006 Feb; 80(3):1271-9. PubMed ID: 16415004
[TBL] [Abstract][Full Text] [Related]
31. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions.
Ivanyi-Nagy R; Kanevsky I; Gabus C; Lavergne JP; Ficheux D; Penin F; Fossé P; Darlix JL
Nucleic Acids Res; 2006; 34(9):2618-33. PubMed ID: 16707664
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II.
Lyons AJ; Lytle JR; Gomez J; Robertson HD
Nucleic Acids Res; 2001 Jun; 29(12):2535-41. PubMed ID: 11410661
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA.
Yoo JS; Kim CM; Kim JH; Kim JY; Oh JW
Antiviral Res; 2009 Jun; 82(3):122-33. PubMed ID: 19428603
[TBL] [Abstract][Full Text] [Related]
34. A novel sequence found at the 3' terminus of hepatitis C virus genome.
Tanaka T; Kato N; Cho MJ; Shimotohno K
Biochem Biophys Res Commun; 1995 Oct; 215(2):744-9. PubMed ID: 7488017
[TBL] [Abstract][Full Text] [Related]
35. A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.
Caldarelli SA; Mehiri M; Di Giorgio A; Martin A; Hantz O; Zoulim F; Terreux R; Condom R; Patino N
Bioorg Med Chem; 2005 Oct; 13(20):5700-9. PubMed ID: 16061387
[TBL] [Abstract][Full Text] [Related]
36. A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins.
Rijnbrand R; Yang Y; Beales L; Bodola F; Goettge K; Cohen L; Lanford RE; Lemon SM; Martin A
Hepatology; 2005 May; 41(5):986-94. PubMed ID: 15793797
[TBL] [Abstract][Full Text] [Related]
37. A cellular protein specifically binds to the 3'-terminal sequences of hepatitis C virus intermediate negative-strand RNA.
Wang W; Deng Q; Huang K; Duan Z; Shao J; Huang Z; Huang Z
Chin Med J (Engl); 2003 Jun; 116(6):932-6. PubMed ID: 12877810
[TBL] [Abstract][Full Text] [Related]
38. Human initiation factor eIF3 subunit b interacts with HCV IRES RNA through its N-terminal RNA recognition motif.
Pérard J; Rasia R; Medenbach J; Ayala I; Boisbouvier J; Drouet E; Baudin F
FEBS Lett; 2009 Jan; 583(1):70-4. PubMed ID: 19059401
[TBL] [Abstract][Full Text] [Related]
39. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
[TBL] [Abstract][Full Text] [Related]
40. Analyses of subgenomic promoters of Hibiscus chlorotic ringspot virus and demonstration of 5' untranslated region and 3'-terminal sequences functioning as subgenomic promoters.
Li W; Wong SM
J Virol; 2006 Apr; 80(7):3395-405. PubMed ID: 16537607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
